secwatch.observer — SEC 8-K summary
======================================

Issuer:     AGENUS INC (AGEN)
CIK:        0001098972
Form:       8-K
Filed at:   2025-10-09T23:59:59+00:00
Accession:  0001193125-25-235819
Event type: debt
Sentiment:  neutral
Materiality: 0.55
Item codes: 1.01, 2.03
LLM model:  deepseek-v4-flash:cloud@v2

Agenus enters $10M promissory note with Zydus; bears 3.81% interest, secured by 822,910 INKT shares
--------------------------------------------------------------------------------

- Up to $10M note at 3.81% p.a.; matures at APA/SPA closing or 10 days after notification that closing will not occur.
- Proceeds fund Q4 2025 operational expenses of Emeryville and Berkeley facilities; forgiven if APA/SPA closes.
- Collateral: 822,910 shares of MiNK Therapeutics (NASDAQ: INKT); control agreement provides Zydus rights upon default.
- Bridge financing tied to pending Zydus asset purchase; facility expense amounts forgiven if deal closes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1098972/000119312525235819/0001193125-25-235819-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1098972/000119312525235819/agen-20251008.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-235819

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer